SE8008428L - N-adamantansubstituerade tetrapeptidamider - Google Patents

N-adamantansubstituerade tetrapeptidamider

Info

Publication number
SE8008428L
SE8008428L SE8008428A SE8008428A SE8008428L SE 8008428 L SE8008428 L SE 8008428L SE 8008428 A SE8008428 A SE 8008428A SE 8008428 A SE8008428 A SE 8008428A SE 8008428 L SE8008428 L SE 8008428L
Authority
SE
Sweden
Prior art keywords
substituted
tetrapeptidamides
adamantan
amino acid
acid residues
Prior art date
Application number
SE8008428A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
R H Mazur
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE8008428L publication Critical patent/SE8008428L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8008428A 1979-12-03 1980-12-02 N-adamantansubstituerade tetrapeptidamider SE8008428L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/099,765 US4273704A (en) 1979-12-03 1979-12-03 N-Adamantane-substituted tetrapeptide amides

Publications (1)

Publication Number Publication Date
SE8008428L true SE8008428L (sv) 1981-06-04

Family

ID=22276513

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8008428A SE8008428L (sv) 1979-12-03 1980-12-02 N-adamantansubstituerade tetrapeptidamider

Country Status (16)

Country Link
US (1) US4273704A (es)
JP (1) JPS5692847A (es)
AU (1) AU6499080A (es)
BE (1) BE886472A (es)
CA (1) CA1151642A (es)
DE (1) DE3044793A1 (es)
DK (1) DK513480A (es)
ES (2) ES8205753A1 (es)
FR (1) FR2476073A1 (es)
GB (1) GB2066262B (es)
IT (1) IT1127930B (es)
NL (1) NL8006586A (es)
NO (1) NO803640L (es)
PT (1) PT72141B (es)
SE (1) SE8008428L (es)
ZA (1) ZA807513B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404135A (en) * 1981-07-20 1983-09-13 G. D. Searle & Co. Enkephalin derivatives
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide
US4629784A (en) * 1983-08-16 1986-12-16 The University Of Georgia Research Foundation, Inc. Synthesis of cyclopropane amino acids
DE3485587D1 (de) * 1983-08-16 1992-04-23 Univ Georgia Res Found Herstellung von aminocyclopropancarbonsaeuren und von peptiden.
US4510085A (en) * 1984-04-12 1985-04-09 G.D. Searle & Co. Antihypertensive tetrapeptide amides
US4514332A (en) * 1984-04-16 1985-04-30 G. D. Searle & Co. Tetrapeptide adamantyl amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
US4822775A (en) * 1986-02-14 1989-04-18 G. D. Searle & Co. Phenyl substituted dipeptide amides
US4880829A (en) * 1985-08-14 1989-11-14 G. D. Searle And Company Substituted dipeptide amides #3
US4758675A (en) * 1986-07-14 1988-07-19 G. D. Searle & Co. 3-thiophene-substituted tyrosyl dipeptide amides
EP0668290B1 (en) * 1990-02-28 1998-11-11 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US6468487B1 (en) 1997-01-14 2002-10-22 Daicel Chemical Industries, Ltd. Nitration or carboxylation catalysts
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US7880001B2 (en) * 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20050261302A1 (en) * 2004-04-29 2005-11-24 Hoff Ethan D Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
US8415354B2 (en) * 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20050245534A1 (en) * 2004-04-29 2005-11-03 Link James T Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
EP1812407A2 (en) * 2004-11-02 2007-08-01 Pfizer, Inc. Novel compounds of substituted and unsubstituted adamantyl amides
US8198331B2 (en) * 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
JP5078621B2 (ja) 2005-01-05 2012-11-21 アボット・ラボラトリーズ １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型酵素の阻害薬としてのアダマンチル誘導体
HRP20050242B1 (en) * 2005-03-15 2010-09-30 Institut Ruđer Bošković Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
JP5736098B2 (ja) * 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
EP2399926A1 (en) * 2010-06-22 2011-12-28 Justus-Liebig-Universität Giessen Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents
CN112552374B (zh) * 2019-09-10 2024-06-04 西藏海思科制药有限公司 一种肽酰胺类化合物及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732451A1 (de) * 1976-07-27 1978-02-02 Reckitt & Colmann Prod Ltd Peptidverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Also Published As

Publication number Publication date
GB2066262A (en) 1981-07-08
DK513480A (da) 1981-07-09
CA1151642A (en) 1983-08-09
PT72141A (en) 1981-01-01
IT1127930B (it) 1986-05-28
ES497353A0 (es) 1982-06-16
ES8300087A1 (es) 1982-10-01
ZA807513B (en) 1982-07-28
DE3044793A1 (de) 1981-06-19
NO803640L (no) 1981-06-04
ES8205753A1 (es) 1982-06-16
GB2066262B (en) 1983-05-11
US4273704A (en) 1981-06-16
ES508060A0 (es) 1982-10-01
BE886472A (fr) 1981-06-03
NL8006586A (nl) 1981-07-01
JPS5692847A (en) 1981-07-27
PT72141B (en) 1981-10-28
AU6499080A (en) 1981-06-11
IT8050294A0 (it) 1980-12-02
FR2476073A1 (fr) 1981-08-21

Similar Documents

Publication Publication Date Title
SE8008428L (sv) N-adamantansubstituerade tetrapeptidamider
DE3366428D1 (en) Dynorphin amide analogs
ES2229045T3 (es) Derivados de peptidos terapeuticos.
MC2040A1 (fr) Derives d'acides amines
BRPI9814499A (pt) Peptídeo amida opióide sintético ou um sal farmaceuticamente aceitavel do mesmo, e, composição farmacêutica
MC2022A1 (fr) Derives d'acides amines
ES2159528T3 (es) Amantadina y compuestos asociados para su utilizacion en el tratamiento de la neuropatia periferica dolorosa.
DE3381282D1 (de) Peptidverbindungen.
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
DE3689508D1 (de) Peptide.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
DE68909362D1 (de) (2R,3S,4S)-Alpha-(carboxycyclopropyl)glycin.
DE69012901D1 (de) Hämoregulierende Peptide.
ES2079402T3 (es) Un proceso para la preparacion de hidrocloruro de ester metilico de alfa-l-aspartil-l-fenilalanina mediante el uso de anhidrido n-formil-aspartico aislado.
GB2217331C (en) Oligopeptides and their use as analgesics
ATE16495T1 (de) Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
ATE92078T1 (de) Pharmakologisch aktive peptide.
DK77583D0 (da) N-(n'-(2-chlorethyl)-n'-nitrosocarbamoyl)-oligopeptidestere og -amider samt fremgangsmade til deres fremstilling
FR2777279B1 (fr) Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide
MX9207372A (es) Sal hidrocloruro de un ester alquilico de un oligopeptido o de un aminoacido y procedimiento para su preparacion.
IT8848190A0 (it) 2-[n-(3,4-dimetossifenil-1,3-ditiano-1,1,3,3,-tetraossido-3-propil)ammino]-6,7-dimetossi tetraline
SE8001037L (sv) Sett att klorera karboxylgruppen hos alfa-aminosyror
FR2710241B3 (fr) Composition énergétique à base d'acides aminés glycogéniques.
NO920020L (no) N-(merkaptoalkyl)amider
KR930700533A (ko) 교원효소 억제활성을 갖는 포스포노펩티드

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8008428-8

Format of ref document f/p: F